Guilford, Conn.-based online advertising start-up uKnow has raised roughly half of a planned $1 million funding round, according to a filing with the SEC. Angel investor Geoff Judge, who is also a partner with iNovia Capital, is listed among the company’s directors.
Pittsburgh-based Neograft has raised $3 million according to an SEC filing. Neograft develops medical devices that treat coronary artery disease. The comany’s Angioshield device is designed to provide controlled temporary structural support to veins intended for use as arterial vein grafts.
Sunnyvale, Calif.-based company Cambrios Technologies, raised at least $2.5 million of a planned $15 million round which will include both equity and debt financing, according to a filing with the S.E.C. The company was formed in 2002, and last year closed on $14.5 million in financing from investors including ARCH Venture Partners, Alloy Ventures, Oxford Bioscience Partners, Altitude Life Science Ventures, Presidio Ventures, Mitsubishi UFJ Capital, In-Q-Tel, Avalon Ventures, Lux Capital, and Headland Ventures.
LiquidSpace has raised $1.3 million in seed financing, according to a filing with the S.E.C. According to its website, the Palo Alto-based company is developing technology to help users work productively outside of the office – from their homes, cars or other locations. Floodgate Managing Partner Mike Maples is among the company’s backers, according to the filing.
San Francisco-based Utique, which makes vending machines designed to sell high-end beauty products, has raised $3.6 million, according to an S.E.C. filing. Michael Jesselson, who runs private investment firm Jesselson Capital Corp., is listed as a director of the company, according to the filing.
Limerick BioPharma Inc., a South San Francisco-based developer of technology designed to improve drug efficacy, has added $3.5 million in equity and debt financing, according to a filing with the S.E.C. In 2009, the company closed on $15 million in Series C funding from OVP Venture Partners, ARCH Venture Partners, Sevin Rosen Funds and Altitude Funds. The company was founded as Limerick Neurosciences in late 2004.